Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice their appetite shifting within the first one to two weeks of starting Mounjaro, though meaningful weight changes typically take four to eight weeks to become visible on the scales. The full effect builds over months, not days, because the medicine is titrated gradually. Mounjaro is a prescription-only medicine; a clinician decides whether it is suitable for you, and the timeline varies from person to person. Understanding what to expect at each stage helps you stay patient and spot when things are working — even before the number on the scale moves.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is the question almost everyone asks after their first injection. The honest answer is: probably not on the scales, but possibly in your head, in the best way.
Mounjaro activates two gut-hormone receptors (GIP and GLP-1) that signal fullness and slow how quickly the stomach empties. That mechanism can start working almost immediately after the first dose, which is why some people report that food noise (the background chatter of constant hunger) quietens noticeably in the first week. Others feel very little change at 2.5 mg and that is equally normal. If you are curious about how quickly Mounjaro takes effect, the short answer is that some hormonal signalling begins within hours of the first injection, even if the scales stay stubbornly still. The shift in food noise is often the earliest and most telling sign that Mounjaro is doing something, even when the scales are unmoved.
What you almost certainly will not see in week one is a dramatic drop in weight. The body does not work that way, and the starting dose is intentionally low. Its job is to let your system settle, reducing the chance of nausea or other gastrointestinal discomfort, not to produce immediate fat loss. Think of it as calibration. Expecting big numbers in the first fortnight sets a bar that the medicine was never designed to clear that quickly, and disappointment at that stage causes some people to stop before the real work begins.
The NHS's patient-level guidance on tirzepatide notes that effects accumulate with continued treatment, which aligns with how the titration schedule is designed. You can read more at the NHS tirzepatide medicines page.
From around week two onwards, the signals tend to become clearer. Portions feel more manageable. The urgency around meals softens. Some people find they leave food on the plate for the first time in years, not through willpower, but because they genuinely feel full sooner.
Weight loss typically becomes measurable around weeks four to eight. For some, it arrives earlier; for others it takes longer, particularly at lower doses. A loss of one to two pounds per week once momentum builds is a reasonable expectation, though individual variation is wide. The titration schedule means your dose will likely increase after four weeks, and each step up often brings a fresh wave of effect, appetite suppression sharpens, and weight loss may accelerate.
It is worth keeping a simple log during this phase. Bodyweight fluctuates day to day because of water retention, hormones and what you have eaten, so weighing yourself once a week at the same time (morning, before eating) gives a more reliable picture than daily weigh-ins. If you started treatment through a regulated service, the clinical review before each repeat order is a good moment to discuss your progress, a prescriber can help you interpret what you are seeing. You can find more detail on the full response curve at /pages/how-long-does-it-take-for-mounjaro-to-take-effect.
One practical note on timing: if your order arrives just before a bank holiday or you are mid-travel when your next pen is due, a brief interruption can briefly reset some of the appetite effects. Planning ahead (even for something as ordinary as a payday-month delivery window or a summer holiday) avoids unnecessary gaps that slow your momentum.
This is the window in which most people move from noticing a difference to seeing one. The SURMOUNT-1 trial, published in the New England Journal of Medicine, recorded an average weight reduction of around 20–21% at the highest dose over 72 weeks, a figure achieved through consistent titration and lifestyle changes alongside the medicine, not through the first few injections alone. That trial enrolled thousands of adults with obesity and remains the core evidence base for tirzepatide's effectiveness.
The practical implication is that patience through the first three months is not passive, it is the work. Your prescriber is titrating your dose, your body is adapting, and your eating patterns are shifting. By month three, most people on a therapeutic dose are in a phase of steady, measurable loss.
Side effects, if they appear, are also most common in this early-to-mid period, typically around dose increases. Nausea, loose stools or tiredness after an injection are reported by many patients and generally settle within a few days. They are not a sign that the medicine is not working; often the opposite. The full Mounjaro overview covers the side-effect profile in more detail, and our clinical team at nume, sorry, at our pharmacy can address specific concerns through aftercare. For a broader look at how the speed of effect compares across the titration steps, the page on how fast Mounjaro takes effect goes deeper into dose-by-dose responses.
For the majority of people who stay on Mounjaro through to a maintenance dose and maintain the lifestyle changes recommended alongside it, results continue to build well beyond the six-month mark. The 72-week SURMOUNT-1 figures were not a six-month snapshot, they reflect over a year of treatment.
What does warrant a conversation with your prescriber? If you have been on the highest tolerated dose for six months and weight loss is under 5%, NICE's guidance on tirzepatide suggests that continuing may not be the right path, an important safety-net review rather than a reason to give up early. You can read that recommendation directly in NICE's appraisal of tirzepatide (TA1026).
Equally, there is no single correct speed. Slower progress at a lower dose does not mean the treatment is failing; it may mean titration is paced appropriately for you. The question of how quickly Mounjaro gets into your system and starts influencing hormones is answered separately at this page on absorption and onset.
If you have questions about how your own timeline compares, or you are considering starting treatment, our free consultation connects you with a GPhC-registered prescriber who reviews your case personally. That review happens the same day, and it is the right place to build a realistic plan for your situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.